Global OSDF Excipients Demand is Expected to Reach 126.8 kilo tons in 2018: Transparency Market Research

According to a new market report published by Transparency Market Research “Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market for Polymers (MCC, HPMC, CMC, Ethyl Cellulose, Povidone and Others), Alcohols (Glycerin, Sorbitol, Mannitol, Propylene Glycol), Minerals (Clay, Silicon Dioxide, Titanium Dioxide) and Sugars (Lactose, Sucrose) - Global Industry Analysis, Size, Share, Trends, Analysis, Growth and Forecast, 2012 – 2018,” the global OSDF excipients demand was 93.8 kilo tons in 2011 and is expected to reach 126.8 kilo tons in 2018, growing at a CAGR of 4.5% from 2012 to 2018. In terms of revenue, the market was valued at USD 570.6 million in 2011 and is expected to reach USD 869.1 million in 2018, growing at a CAGR of 6.3% from 2012 to 2018. The overall pharmaceutical excipients demand was 519.5 kilo tons in 2011 and is expected to reach 685.6 kilo tons in 2018, growing at a CAGR of 4.1% from 2012 to 2018.

Browse the full report at http://www.transparencymarketresearch.com/pharma-excipient-market.html

The growth of the global pharmaceutical market on account of increasing aging population particularly in countries such as U.S. and Japan coupled with the development and introduction of new excipients which exhibit improved properties such as flowability is expected to drive excipients demand over the next five years. However, high costs of manufacturing, stringent government approval process and shortage of approved sites by the Food and Drug Administration (FDA) are expected to hamper the growth of this market.

Polymers were the largest consumed product segment for overall and OSDF excipients market and accounted for over 30% of the global market in both forms. Sugar and other excipient products are expected to witness the fastest growth rate over the forecast period. Within the mineral excipients market, calcium phosphate and calcium carbonate are expected to dominate the market over the next six years. Lactose and sucrose forms of sugar excipients are expected to be the key market segments over the next few years.

Consumption of overall excipients was highest in Europe accounting for approximately 160 kilo tons in 2011. Demand for OSDF excipients was also highest from Europe accounting for over 30% of the total volume in 2011. However, the highest demand for Overall and OSDF excipients is expected from Asia Pacific due to the growth of the medical and food industry. In addition, increasing aging population in countries such as China and Japan are expected to contribute to the demand for excipients.

Some of the key participants profiled in the report include AkzoNobel, BASF, Cargill, Croda International Plc, Dow Chemical Company, Eastman Chemical Company, Evonik, Innophos Holdings Inc., The Lubrizol Corporation and Royal Dutch Shell Plc among others.

The report gives a comprehensive view of the excipients market in terms of volume and revenue. In addition, the report includes the demand forecast for each product type, based on volume and revenue. The report comprises the following segments:

Global Overall and OSDF Excipients Market: Product Segment Analysis

§  Polymers

§  Alcohols

§  Minerals

§  Gelatin

§  Sugar and Others

The report further segments the Overall and OSDF excipients product segments as:

Global Overall and OSDF Polymer Excipients Market: Product Segment Analysis

§  MCC

§  HPMC

§  Ethyl Cellulose

§  Methyl Cellulose

§  CMC

§  Croscarmellose Sodium

§  Povidone

§  Pregelatinized starch

§  Sodium starch glycolate

§  Polyethylene Glycol

§  Acrylic Polymers

Global Overall and OSDF Alcohol Excipients Market: Product Segment Analysis

§  Glycerin

§  Propylene Glycol

§  Sorbitol

§  Mannitol

§  Others

Global Overall and OSDF Alcohol Excipients Market: Product Segment Analysis

§  Calcium Phosphate

§  Calcium Carbonate

§  Clay

§  Silicon Dioxide

§  Titanium Dioxide

§  Others

Global Overall and OSDF Sugar and Other Excipients Market: Product Segment Analysis

§  Lactose

§  Sucrose

§  Others

The report provides a cross-sectional analysis of Overall and OSDF excipients with respect to the following regions:

§  North America

§  Europe

§  Asia Pacific

§  Rest of the World

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Sheela AK

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Visit: http://www.transparencymarketresearch.com/

Browse the full report with TOC at http://www.transparencymarketresearch.com/pharma-excipient-market.html

China’s efforts in placing a nationwide smoking ban by end of the year 2014

In an effort to reduce tobacco products, China – being the world’s biggest consumers of tobacco desires to put an end to the nation-wide ban on smoking in open public places.

The National Health and Family Planning Commission in China is highly concerned about the nearly growing 300 million smokers in the country, and thus, continues to pressurize the lawmakers to lay down stricter laws on using tobacco in public places as well as in the country, said the Reuters.

The commission has recommended different options for reducing the use of tobacco. This includes banning smoking in all schools and hospitals, and seeking more education on the threats and dangers of tobacco around us. According to the Reuters, smoking has taken a major toll on the Chinese health as it is used in most of the essential places of the society and socializing events.

As compared to the sheer damage that smoking causes in humans, tobacco’s economic advantages are critical and trivial, said Mao Qun'an, a spokesman for the commission at a news conference.  

Many experts in China tried to minimize the use of tobacco in the country, but the country’s powerful tobacco industry mired the respective measures by placing health warning s and not permitting tobacco prices. The government circulars requested the government officials to avoid smoking in public places. According to the Reuters, this was the best example set by the government.

A nationwide ban has been effectuated in China on a very serious scale, and furthermore, places like Beijing began this prohibition of smoking in public venues and different government offices. However, the lack of enforcing the ban has not affected China’s goal in reducing smoking though. There are many people in the country who still ignore the signs of ban on smoking in public places.

Short-Term ARV benefits during early HIV Infection

Taking short courses of antiretrovirals (ARVs) during the primary, or early, HIV infection (PHI) stages provide immunological benefits for at least a year after breaking the rhythm of the treatment, reported aidsmap.

These findings were published in PLOS ONE, whereby, a group of researchers conducted a meta-analysis of nearly eight studies of treatment taking place during the PHI. This resulted in both, a control arm and a treatment.

Moreover, the medical studies that were published between the phases 2004 and 2012 consisted of cohorts spanning from 11 to 822 participants. They took the courses for between 12 and 86 weeks, followed by nine months and six years after the intermittent treatment.

Nonetheless, a year after stalling the ARV treatment, those who had an early treatment witnessed a minimum increase of 86 CD4 cells, and had their viral load resulted into half its value. This was compared to the control group. And the ones who received their treatment experienced lower CD4 counts and viral load measurements.

When the researchers analyzed the data, they found that the benefits of early treatment were far lower than the regular, but after adjusting the results, they examined even greater benefits to the early treatment.

The early treatment was mainly beneficial to those who had begun at lower CD4s but at a higher viral load. 

Chip Maker Intel Vows to Avoid Sourcing ‘Conflict Minerals’

After the concept of sourcing ‘conflict free’ diamonds and metals has gained popularity the world over, globally leading chip maker Intel has now taken a pledge to support this cause. Intel recently announced at the CES in Las Vegas that it has pledged to refrain from sourcing raw material such as minerals from the company’s factories that are located in areas that predominantly witness human rights being abused.

The manufacturing process of computer chips relies heavily on elements such as tungsten, gold, and silver. However, these metals are typically sourced (mined and smelted) from countries where human rights violations are a major cause of concern. These countries include the Democratic Republic of the Congo (DRC). In these regions, workers are subjected to poor treatment and the profits earned from operations here are typically used for funding armed conflicts among local factions that fight to gain a larger share in the mineral mining business here.

According to human rights experts, violent acts of abuse have mostly been noted in the conflicts that are carried out to gain control of the mineral wealth that abounds in this region.

Just six months into his job as the chief executive of Intel, Brian Krzanich announced at the CES that though the company considers minerals an important part of the chip making process, the people engaged in mining these minerals are far more important.

The United Nations Security Council Committee had, in a recent report stated that electronics products are often carriers of ‘conflict minerals’.

Krzanich further added that the company has taken the step to avoid sourcing ‘conflict minerals’ as it is concerned about the potential impact that could be caused by these problems on the supply chain. The company’s final decision comes after a complete audit of its supply chain. 

World Bank Considers India’s Solar Power Projects Lucrative

This could well be the boost that the Indian solar power industry needed to emerge as a leader on the global scenario. The World Bank considers the country’s Jawaharlal Nehru National Solar Mission 2010 a project that’s “well-poised” to help India gain the definitive tag of a global leader in solar power development. The mission was set up with the goal of installing 20 GW of solar power by the end of 2020. In 2010, the installed solar capacity was just 30MW and it grew to a whopping 2,000 MW in 2013.

These are the observations of a report titled “Paving the Way for a Transformational Future: Lessons from JNNSM Phase 1” that was released by the World Bank. The report states that the widespread growth and utilization of solar power can help reduce India’s current dependence on imported fuel. Further, it can also curtail emissions of greenhouse gas and help contribute to India’s energy security.

The WB is particularly impressed by the fact that India has made unprecedented progress in developing solar power over a period of three years, proving that it is in a position to make optimum utilization of solar power that is abundantly available in this country. The efficient and effective use of solar power can help the country address its power shortage; it can change the lives of millions of Indians who do not currently have access to power. This would potentially immensely contribute to the cause of economic development.

Looking at the success story of Phase I of the Mission, the World Bank is now in talks with the ministry of new and renewable energy to possible finance solar projects. Funds to the tune of around $13 billion are currently required with the debt requirement component being as high as $9 billion. If things go to plan, it is believed that the World Bank could partially finance the debt component.

India’s Chemco Group to Establish PET Preforms Factory in Bahrain

The Chemco Group, a leading Indian manufacturer of PET jars, has announced plans to set up a plastics packaging unit in Bahrain. The new factory will be established at the Bahrain International Investment Park in Salman Industrial City and will primarily engage in the manufacture of polyethylene terephthalate (PET) preforms. These PET preforms can be converted into PET jars and bottles of various shapes and sizes.

With this decision, Chemco’s investment in Bahrain up to 2015 will likely touch $10 million, eventually expanding in a systematic manner to double by 2017. When the new facility becomes operational, it will likely create 80 locals jobs, and around 20 more jobs would be added as the factory expands by 2017. In this context, a year-on-year growth of 15-20 per cent is expected.

The decision was finalized in a meeting between Chemco Group officials and the Kamal Ahmed, EDB’s acting CEO. The company said that it will look to supply products manufactured at this facility to both regional as well as local companies. The Chemco Group will be able to gain a license for operations in Bahrain with the support of the EDB, is primarily engaged in attracting FDI into Bahrain.

Ram Saraogi, the MD and chairman of the Chemco Group, the company zeroed in on Bahrain as it offers a unique business environment and an economy that is diverse while also offering a locational advantage from the Gulf market standpoint. The Chemco Group boasts a 26% market share in the PET preforms market in Asia; it was established in 1980. Its PET bottles are used in a variety of industries such as food and beverages and other products for brands such as Pepsi, Coca Cola and Reckitt Benckiser.

Pain Management Devices Market is Expected to Reach USD 5.0 Billion Globally in 2018: Transparency Market Research

According to a new market report published by Transparency Market Research , "Pain Management Devices Market (Electrical Stimulators, Radiofrequency Ablation, Analgesic Pumps, Neurostimulation Devices) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018", in 2011, the global pain management devices market was valued at USD 2.0 billion and is expected to grow at a CAGR of 13.1% from 2012 to 2018 to reach a market of USD 5.0 billion by 2018.

Browse the full report at: http://www.transparencymarketresearch.com/pain-management-drugs-devices.html

Increased sophistication and technological advances have revolutionized the pain management sector. Significant research to understand various pain sensations and their neurotransmission processes has helped in pain reduction to a great extent. A rise in aging population has consequently led to a rise in chronic diseases such as arthritis, diabetes and cancer. In addition, serious side-effects caused due to prolonged use of pain management drugs have triggered the growth of the pain management devices market.

Pain management devices comprise a variety of instruments such as electrical stimulators, analgesic pumps, radiofrequency ablation and neurostimulation devices. Robust support from healthcare institutes, universities and hospitals coupled with positive involvement from government bodies has unquestionably assisted in further growth of this sector. Companies in this sector are collaboratively working towards the introduction of innovative products which would satisfy the unmet needs of patients. Moreover, limitations like miniaturization, achievement of read out time and cost efficiency are being worked on by all the major players of this market.

Electrical stimulators especially the TENS (Transcutaneous Electrical Nerve Stimulators) are currently the most widely used by patients. The market for electrical stimulators was valued to be USD 208.7 million in year 2011 and is expected to grow at a CAGR of 8.2% from year 2012 to 2018. Although electrical stimulators and analgesic pumps are currently the most commonly used devices, radiofrequency ablation (RF ablation) and neurostimulation devices are anticipated to register high growth rate in the coming years of forecast. The rise in neuropathic diseases such as trigeminal neuralgia, peripheral neuralgia and spinal injuries has encouraged the growth of the neurostimulation devices market, which is slated to grow at a CAGR of 15.2% from 2012 to 2018.

Geographically, the North American region constituted the largest market in the year 2011; however, Asia is predicted to foresee the highest growth rate of 21.7% from 2012 to 2018. This growth has been attributed to increase in disease awareness and rising disposable incomes. In addition, the Asian region has been predicted to have the highest incidence rates of cancer and diabetes by 2020, by the World Health Organization. Favorable reimbursement policies and research funding by governments in the region will also provide the required impetus for the growth of the market.

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Sheela AK

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Browse the full report with TOC at: http://www.transparencymarketresearch.com/pain-management-drugs-devices.html